OTC Markets EXMKT - Delayed Quote USD
Bonus BioGroup Ltd. (BBIXF)
0.0300
0.0000
(0.00%)
As of April 23 at 4:00:00 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Cost of Revenue
2,509
2,509
2,952
3,366
4,097
Gross Profit
-2,509
-2,509
-2,952
-3,366
-4,097
Operating Expense
25,327
25,327
26,838
33,681
60,638
Operating Income
-27,836
-27,836
-29,790
-37,047
-64,735
Net Non Operating Interest Income Expense
-254
-254
762
-615
-593
Pretax Income
-27,826
-27,826
-28,529
-38,703
-90,076
Net Income Common Stockholders
-27,826
-27,826
-28,529
-38,703
-90,076
Diluted NI Available to Com Stockholders
-27,826
-27,826
-28,529
-38,703
-90,076
Basic EPS
-0.04
--
-0.05
-0.06
-0.16
Diluted EPS
-0.04
--
-0.05
-0.06
-0.16
Basic Average Shares
624,423.8700
--
623,334.7990
623,167.5880
579,121.1740
Diluted Average Shares
624,423.8700
--
623,334.7990
623,167.5880
579,121.1740
Total Operating Income as Reported
-27,836
-27,836
-29,790
-37,047
-64,735
Rent Expense Supplemental
1,573
1,573
1,475
1,527
858
Total Expenses
27,836
27,836
29,790
37,047
64,735
Net Income from Continuing & Discontinued Operation
-27,826
-27,826
-28,529
-38,703
-90,076
Normalized Income
-27,805
-27,805
-28,529
-30,680
-69,258
Interest Income
543
543
1,641
293
--
Interest Expense
779
779
848
891
569
Net Interest Income
-254
-254
762
-615
-593
EBIT
-27,047
-27,047
-27,681
-37,812
-89,507
EBITDA
-24,254
-24,254
-24,920
-35,149
-88,031
Reconciled Cost of Revenue
2,509
2,509
2,952
3,366
4,097
Reconciled Depreciation
2,793
2,793
2,761
2,663
1,476
Net Income from Continuing Operation Net Minority Interest
-27,826
-27,826
-28,529
-38,703
-90,076
Total Unusual Items Excluding Goodwill
-21
-21
--
-8,023
-20,818
Total Unusual Items
-21
-21
--
-8,023
-20,818
Normalized EBITDA
-24,233
-24,233
-24,920
-27,126
-67,213
12/31/2021 - 7/30/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade